These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs. Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738 [TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220 [TBL] [Abstract][Full Text] [Related]
27. [Family planning in Colombia -- 1987]. Trias M Profamilia; 1987 Sep; 3(9-10):5-9. PubMed ID: 12315078 [TBL] [Abstract][Full Text] [Related]
28. Pill power: oral contraceptives hold top spot in family planning arsenal. Contracept Technol Update; 1998 Oct; 19(10):125-7. PubMed ID: 12321842 [TBL] [Abstract][Full Text] [Related]
29. [Metabolic risks of oral contraception]. Monier L Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576 [TBL] [Abstract][Full Text] [Related]
30. Psychiatrically impaired patients often exposed to pregnancy risk. Neinstein LS; Katz B Contracept Technol Update; 1985 Jun; 6(6):88-90. PubMed ID: 12313658 [TBL] [Abstract][Full Text] [Related]
31. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience. Rubio-lotvin B; Ruiz-moreno JA; Gonzalez-ansorena R Adv Contracept Deliv Syst; 1992; 8(1-2):75-88. PubMed ID: 12285566 [TBL] [Abstract][Full Text] [Related]
32. How to use OCs? Readers offer insights. Contracept Technol Update; 1999 Sep; 20(9):105-6. PubMed ID: 12290377 [TBL] [Abstract][Full Text] [Related]
33. Survey report: Ecuador. Kent MM Popul Today; 1987 Dec; 15(12):5. PubMed ID: 12341909 [TBL] [Abstract][Full Text] [Related]
34. OCs are currently the second most popular birth control method in U.S. Contracept Technol Update; 1985 Jan; 6(1):3. PubMed ID: 12279916 [TBL] [Abstract][Full Text] [Related]
35. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U; Dubois M Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606 [TBL] [Abstract][Full Text] [Related]